Safety of carotid intervention following thrombolysis in acute ischaemic stroke.
نویسندگان
چکیده
OBJECTIVES Thrombolysis is effective in improving clinical outcome in the treatment of acute ischaemic stroke. However, thrombolysis results in low recanalisation rates, particularly in the event of carotid occlusion. Carotid intervention is indicated in stroke resulting from significant carotid atherosclerosis, but intervention soon after thrombolysis may be associated with increased risks. This study aims to assess the safety of carotid intervention post-thrombolysis for acute ischaemic stroke. DESIGN Systematic review. MATERIALS AND METHODS MEDLINE and EMBASE were searched on 29 May 2014. Inclusion criteria were (i) intra-arterial or intravenous thrombolysis for acute ischaemic stroke; (ii) carotid intervention within 14 days of thrombolysis; and (iii) derivable primary outcome. The primary outcome was 30-day stroke or death. A meta-analysis of incidence was completed for the 30-day stroke or death rates using Freeman-Tukey arcsine transformations and assuming random effects. Point estimates with confidence intervals (CIs) were generated and heterogeneity was assessed. The strength of recommendations and quality of underlying evidence were assessed using the American College of Chest Physicians (ACCP) grading system. RESULTS Nine included publications recorded 114 carotid endarterectomy (CEA) and four angioplasty interventions. The point estimate of 30-day stroke or death for CEA was 4.93% (95% CI 1.83-9.44), representing four of 114. The strength of recommendation and quality of underlying evidence for CEA as per the ACCP grading system was determined as 1C. There were no cases of stroke or death in patients undergoing angioplasty post-thrombolysis (0/4). CONCLUSIONS Early CEA post-thrombolysis appears safe, with stroke or death rates similar to that of the operation without thrombolysis. However, the wide CI obtained highlights the uncertainty of this result. Further, we emphasise that this recommendation is supported by low-quality evidence. Additional data are required to confirm the safety of surgery and early endovascular therapy post-thrombolysis.
منابع مشابه
Commentary on: "safety of carotid intervention following thrombolysis in acute ischaemic stroke".
Indications for carotid endarterectomy (CEA) have evolved as stroke services have improved. Hyperacute stroke units are referring more patients with a significant carotid stenosis, some within hours of thrombolysis. In their metaanalysis, Mandavia et al. pooled the evidence to date to attempt to assess 30-day safety of urgent CEA for these patients. However, care must be taken with the interpre...
متن کاملCatheter-based interventions for acute ischaemic stroke
Catheter-based interventions for acute ischaemic stroke currently include clot removal (usually from the medial cerebral artery) with modern stent-retrievers and in one of five patients (who have simultaneous or stand-alone internal carotid occlusion) also extracranial carotid intervention. Several recently published randomized trials clearly demonstrated superiority of catheter-based intervent...
متن کاملA case of acute myocardial infarction 24 hours after acute ischaemic stroke.
Dear Editor, It is well known that thrombolysis for acute myocardial infarction (AMI) may lead to disintegration of pre-existing intracardiac thrombi with subsequent cerebral embolisation. It appears plausible that the same mechanism could apply to patients with cardiac or arterial thrombi who are undergoing intravenous thrombolysis for acute ischaemic stroke. AMI immediately following tissue p...
متن کاملReperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences
The evolution of reperfusion therapy in acute myocardial infarction and acute ischaemic stroke has many similarities: thrombolysis is superior to placebo, intra-arterial thrombolysis is not superior to intravenous (i.v.), facilitated intervention is of questionable value, and direct mechanical recanalization without thrombolysis is proven (myocardial infarction) or promising (stroke) to be supe...
متن کاملAbciximab in acute stroke
The glycoprotein (GP) IIb/IIIa receptor is a platelet-specific adhesion receptor, which is the final pathway of platelet aggregation. It is blocked by abciximab, a chimeric (murine-human) Fab fragment of a monoclonal antibody. Animal studies have shown that GP IIb/IIIa antagonists improve blood flow in the cerebral microcirculation. Angiographic studies performed in patients with acute myocardi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
دوره 48 5 شماره
صفحات -
تاریخ انتشار 2014